Just been reviewing some of the moves from Warren Buffett's playbook, and honestly, there's an interesting disconnect between what the market's pricing in versus what's actually happening with certain holdings. The Oracle of Omaha may have stepped back from day-to-day CEO duties, but his fingerprints are all over Berkshire's portfolio right now.

So here's the thing that caught my attention. Consumer debt in the U.S. just hit a record $18.8 trillion, and loan delinquencies are creeping up to near-decade highs around 4.8%. You'd think every lender would be sweating bullets, but that's not the full picture. American Express is holding its own better than most because they're not dealing with the typical consumer base. Their cardholders skew affluent, and luxury spending actually grew 15% year-over-year last quarter—nearly double the 8% growth in overall billed business. The stock pulled back almost 20% from December highs on economic concerns, but for a lender with this kind of customer profile, that pullback might be the discount you're waiting for.

Then there's Constellation Brands, which Warren Buffett picked up late last year. Yeah, shares are down since then, and alcohol consumption in the U.S. hit a multidecade low at 54% of the population. But here's what people are missing: this is cyclical. When consumer confidence bounces back, so does demand. Plus, the company's already restructuring—they dumped some lower-margin wine brands that were more noise than profit. New leadership coming in should shake things up too.

Now, not every bet Warren Buffett's made has aged well. DaVita, the dialysis operator, is a good example. Back in 2011 when Berkshire first invested, the fundamentals were solid. Fast forward though, and reimbursement pressures have crushed margins. Revenue is up 5% year-over-year, but net income dropped 17%. The whole healthcare sector is wrestling with this, and Berkshire's been quietly exiting the position for over a year now. That's telling.

The market's definitely rewarding patience in some spots and punishing it in others. If you're tracking these kinds of plays, definitely worth keeping an eye on what's working versus what's become a drag. Gate's got solid data on all these if you want to dig into the charts yourself.